“Liquid biopsies” alert people with advanced breast cancer when new treatments stop working, allowing patients to switch to more effective therapies before their tumors grow larger.
#asco25 #asco2025 #bcsm
www.nbcnews.com/news/amp/rcn...
'Liquid biopsies' alert advanc...
#bcsm
RT by @EMA_News: Join us on 19 October for a Conversations on Cancer panel discussion with the European Medicines Agency @EMA_News on metastatic breast cancer. 9:30am ET/3:30pm Central European time.
Info: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/conversations-cancer-living-metastatic-breast-cancer-10192023
🐦🔗: https://nitter.cz/FDAOncology/status/1710035911939912073#m
[2023-10-05 20:55 UTC]
RT by @EMA_News: Join us on 19 October for a Conversations on Cancer panel discussion with the European Medicines Agency @EMA_News on metastatic breast cancer. 9:30am ET/3:30pm Central European time.
Info: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/conversations-cancer-living-metastatic-breast-cancer-10192023
🐦🔗: https://nitter.cz/FDAOncology/status/1712119143875375109#m
[2023-10-11 14:53 UTC]
Sometimes companies do the bizarrest things...
Why would you make a 4 pack of #fulvestrant?
So I went to get a breast ultrasound today at a breast cancer medical center and while all the clinicians were masked (just baggy blues) some of the receptionists were not and I was the only patient in a mask. And this at a cancer center! #CovidIsNotOver #BCSM #WearAMask
Thank you to the #MedTwitter #OncTwitter community - We couldn't have successful #TumorBoardTuesday without your support, encouragement, and engagement!
#LCSM #BCSM #GITwitter #PanCan #GU #HemOnc
#breastcancersurvivor #breastcancercare #lifestyle #lifestylemedicine #preventativecare #preventativemedicine #preventativehealth #Prevention #diet #exercise #breastcancerawareness #breastcancersupport #breastcancerfighter #breastcancerresearc #breastcancerawarenessmonth #breastcancerwarrior #triplenegativebreastcancer #clinicalresearch #medicine #MedTwitter #onctwitter #bcsm #survonc #mednewsweek #fda #research #design #design #canada #europe #project #data
#clinicalresearch #survivorship #breastcancersurvivor #breastcancercare #lifestyle #lifestylemedicine #preventativecare #preventativemedicine #preventativehealth #Prevention #diet #exercise #breastcancerawareness #breastcancersupport #breastcancerfighter #breastcancerresearc #breastcancerawarenessmonth #breastcancerwarrior #triplenegativebreastcancer #clinicalresearch #medicine #MedTwitter #onctwitter #bcsm #survonc #mednewsweek #fda #research #design #design #canada #europe #project #data
New data supporting a deeper #ESR1 variant characterization in #BreastCancer. Y537S is resistant to #SERD #SERM due to stable conformation and activity. L536 shows varying sensitivity, greatest resistance: AZD9833 GDC-0810 RAD1901 #PrecisionMedicine #bcsm
#breastcancerawareness #breastcancersupport #breastcancerfighter #breastcancerresearc #breastcancerawarenessmonth #breastcancerwarrior #triplenegativebreastcancer #clinicalresearch #medicine #bcsm #survonc #nutrition #research #healthcare #leadership #university #health #medical #innovation #development #hospital #riskmanagement #society #leader #event #school #clinicaltrials #business #community #project #education #work #network #like #mednewsweek
Ongoing and planned Elacestrant clinical trials:
- In brain mets with abemaciclib https://clinicaltrials.gov/ct2/show/NCT04791384?cond=elacestrant&draw=2&rank=7
https://clinicaltrials.gov/ct2/show/NCT05386108?cond=elacestrant&draw=2&rank=6
- In combination with targeted therapies https://clinicaltrials.gov/ct2/show/NCT05563220?cond=elacestrant&draw=2&rank=8
- To treat ctDNA relapse in early HR+/HER2- BC https://clinicaltrials.gov/ct2/show/NCT05512364?cond=elacestrant&draw=2&rank=2
#bcsm (COI)
Elacestrant results publications:
- Phase 1 dose escalation clinical trial: https://pubmed.ncbi.nlm.nih.gov/33513026/
- Phase 1b with FES-PET/CT as a pharmacodynamic biomarker: https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-020-01333-3
- The EMERALD pivotal phase 3 clinical trial: https://ascopubs.org/doi/10.1200/JCO.22.00338?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
First oral #SERD approved for HR+ metastatic #bcsm w/ ESR1 mutation- welcome #elacestrant.
Much more work being done with this class of compounds including: 1) earlier settings, 2) combinations, 3) additional novel oral SERDs coming, 4) benefit in all comers.
@OncoAlert@twitter.com
#Prevention #diet #exercise #breastcancerawareness #breastcancersupport #breastcancerfighter #breastcancerresearc #breastcancerawarenessmonth #breastcancerwarrior #triplenegativebreastcancer #clinicalresearch #medicine #bcsm #survonc #nutrition #research #healthcare #leadership #university #health #medical #innovation #development #hospital #riskmanagement #society #leader #event #school #clinicaltrials #business #community #project #education #work #network #like #mednewsweek
New 📄 in #AdvancesRO
“among patients receiving APBI, surface imaging with daily image guidance is similarly accurate and significantly faster than tattoo-based setup.”
@ErinGillespieMD@twitter.com @LiorBraunstein@twitter.com #radonc #bcsm
https://www.advancesradonc.org/article/S2452-1094(23)00012-X/fulltext?dgcid=raven_jbs_aip_email#.Y9PJEid_QOE.twitter
#OncoAlertColloquium is almost here and my presentation on #bcsm is ready. Advanced #bcsm will air Monday 23rd, 12 noon EST (6PM CET in Europe)
For more information on how you can view the @oncoalert@twitter.com updates from 2022, please visit http://oncoalert360.com/the-oncoalert-colloquium-2022.html
Client Info
Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst